Validation and Standardization of Test Methods and Evaluators for Testing of Hair Care Range of P… (NCT05763888) | Clinical Trial Compass
CompletedNot Applicable
Validation and Standardization of Test Methods and Evaluators for Testing of Hair Care Range of Products
India40 participantsStarted 2023-04-12
Plain-language summary
An exploratory approach for validation and standardization of test methods and evaluators to conduct In-Vivo clinical safety and efficacy testing of hair care range of products.
A total of 40 subjects will be enrolled.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age: 18 - 75 years (both inclusive) at the time of consent.
. Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females).
. Females of childbearing potential must have a self-reported negative urine pregnancy.
. Subject is in good general health as determined by the Investigator on the basis of medical history.
. Subject is willing and able to follow and allow study staff to performed study test methods
. Subject is willing and able to follow the study directions, to participate in the study, returning for all specified visits.
. Subject must be able to understand and provide written informed consent to participate in the study.
Exclusion criteria
. Subject have history of allergy to any ink.
. Subject have participated any clinical research study related to hair care products.
. Subject having history of diabetes
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Evaluate the standardize the methods, procedural steps
Timeframe: Day 01 to Day 04
2
Evaluate the standardize the methods, procedural steps
Timeframe: Day 01 to Day 04
3
Evaluate the standardize the methods, procedural steps
Timeframe: Day 01 to Day 04
4
Evaluate the standardize the methods, procedural steps
Timeframe: Day 01 to Day 04
5
Evaluate the standardize the methods, procedural steps
. Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
. Subject having known history of any skin diseases including eczema, atopic dermatitis or active cancer.